This downtrend has gone to extremes. We are talking about a defensive non-cyclical stock, a pharmaceuticals distributor, with intermediate to short term business troubles. Earnings could be the catalyst here. Despite it being "a falling knife", I'm willing to take some risk on this one.
Note that the RSI has been stabilizing and diverging with prices for a while...
